Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...

For patients with T2D, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and CV event risks.

Q: My doctor is suggesting that I try taking one of those new weight loss drugs -- off-label -- to help me cut down on my alcohol consumption. Does this make any sense? -- Pat R., Ann Arbor, Michigan ...

Weight-loss surgery significantly reduces the risk of psychiatric issues like cognitive decline, anxiety, and substance use ...

Three GLP-1s, liraglutide (Victoza), semaglutide (Ozempic, Wegovy), and dulaglutide (Trulicity) have now been approved to reduce the risks of cardiovascular disease.

The researchers used the model to compare 52 different screening strategies which considered screening of persons aged 35 years or older, 40 years or older, or 45 years or older and annual ...

A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to ...

Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders ...